SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of April 2014
FRESENIUS MEDICAL CARE AG & Co. KGaA
(Translation of registrant’s name into English)
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x | Form 40-F o |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes o | No x |
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82
The following information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.
Representatives of Fresenius Medical Care AG & Co. KGaA (the “Company”) will host a capital markets day in New York City, USA on, April 3, 2014. The event is aimed to discuss the business and affairs of the Company. Interested investors can follow the live webcast of the conference at the Company’s website www.fmc-ag.com under Investor Relations — Presentations. The Conference materials to be presented will be available after the conference at: http://www.fmc-ag.com/5119.htm.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DATE: April 3, 2014
| FRESENIUS MEDICAL CARE AG & Co. KGaA, | ||
| a partnership limited by shares, represented by: | ||
| FRESENIUS MEDICAL CARE MANAGEMENT AG, its | ||
| general partner | ||
|
|
| |
|
|
| |
| By: | /s/ RICE POWELL | |
|
| Name: | Rice Powell |
|
| Title: | Chief Executive Officer and |
|
|
| Chairman of the Management Board |
|
|
| of the General Partner |
|
|
| |
|
|
| |
| By: | /s/ MICHAEL BROSNAN | |
|
| Name: | Michael Brosnan |
|
| Title: | Chief Financial Officer and |
|
|
| Member of the Management Board |
|
|
| of the General Partner |
